Interestingly, the knock‐down of CDK7 by CRISPR/Cas9 preferentially suppressed TNBC cell growth, whereas ER‐positive BC cells were unaffected, demonstrating the high dependency of CDK7 in TNBC. This evidence concerns the gene CDK7 and breast cancer.